Astellas Pharma Europe Ltd. Announces New President of EMEA Operations
Astellas Pharma Europe | March 01, 2016
Astellas Pharma Europe Ltd., a subsidiary of Astellas
Pharma Inc. (TSE:4503), is pleased to announce that Mr Yukio Matsui has been appointed as President of EMEA Operations, with responsibility for the company's commercial operations inEurope, the Middle East and Africa. Yukio will assume his new position on 1st April 2016. Since April 2015, Yukio has served as Senior Vice President, Head of Marketing Strategy for Astellas�� global strategic products.